普健生物(武汉)科技有限公司 服务热线: 18162686757
 
公司首页 公司介绍 公司动态 产品展厅 证书荣誉 联系方式 在线留言
 
 
NEWS新闻资讯

武汉艾必赛生物有限公司推荐Anti-HPV16 L2/Minor capsid protein L2 Antibody (MAb24B) ,精品抗体

发表时间:2026-01-19

链接:https://www.biomart.cn/infosupply/113604043.htm

 

名称:Anti-HPV16 L2/Minor capsid protein L2 Antibody (MAb24B)

 

货号:VK658013

 

种属反应性:Human papillomavirus type (HPV16, HPV18, HPV31, HPV33, HPV35, HPV51, HPV52, HPV58)

 

宿主:Human

 

纯度:>95% as determined by SDS-PAGE.

 

克隆性:Monoclonal

 

同种型:IgG1, kappa

 

应用:WB

 

靶点:Minor capsid protein L2, L2

 

用途范围:仅用于科研

 

储存:Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

 

产品介绍:

Anti-HPV16 L2/Minor capsid protein L2 Monoclonal Antibody (MAb24B) 是一种人源化单克隆抗体,由能够特异性识别人乳头瘤病毒16 型次要衣壳蛋白L2 的高变区(VH/VL)与human IgG1 Fc 片段融合而成。这种结构设计使抗体在结合HPV16 L2 蛋白时兼具高特异性和高亲和力,同时借助IgG1 Fc 片段的稳定性优势,显著提升了Western Blot 等免疫检测实验的灵敏度与重复性。abinScience产品具有亲和力高,灵敏度高,特异性好,稳定性强等优势。

 

产品购买联系方式:027-87433958/17302791434

 

邮箱:info@abinscience.com

新闻图片1

 

参考文献:

The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic traffic. PMID: 22154072

The l2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptors. PMID: 15507604

Efficient Inhibition of Human Papillomavirus Infection by L2 Minor Capsid-Derived Lipopeptide. PMID: 31387913

Human Papillomavirus Type 16 L2 Gene Sequence Variation Analysis in Indonesian Cervical Cancer Specimens. PMID: 35763643

A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11. PMID: 17239496

The evolving field of human papillomavirus receptor research: a review of binding and entry. PMID: 23536685

Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein. PMID: 16257028

HPV16 entry requires dynein for minus-end transport and utilizes kinesin Kif11 for plus-end transport along microtubules during mitosis. PMID: 39629998

Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16. PMID: 12857908

Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes. PMID: 21346798

Direct binding of retromer to human papillomavirus type 16 minor capsid protein L2 mediates endosome exit during viral infection. PMID: 25693203

The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PMID: 22927980

Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach. PMID: 26362430

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV). PMID: 28056100

L2 epitope presenting virus-like particles as broad-spectrum vaccine candidates targeting genus beta human papillomaviruses. PMID: 41333421

Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires gamma-secretase activity. PMID: 25227470

Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression. PMID: 24719459

Human Papillomavirus 16 L2 Recruits both Retromer and Retriever Complexes during Retrograde Trafficking of the Viral Genome to the Cell Nucleus. PMID: 33177206

Cryoelectron Microscopy Maps of Human Papillomavirus 16 Reveal L2 Densities and Heparin Binding Site. PMID: 28065506

Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras. PMID: 23924054

Nuclear import strategies of high risk HPV16 L1 major capsid protein. PMID: 11971900

Efficient delivery of DNA vaccines using human papillomavirus pseudovirions. PMID: 20668481

The cellular endosomal protein stannin inhibits intracellular trafficking of human papillomavirus during virus entry. PMID: 29058661

A chimeric 18L1-45RG1 virus-like particle vaccine cross-protects against oncogenic alpha-7 human papillomavirus types. PMID: 25790098

Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles. PMID: 27147749

Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection. PMID: 20434552

Transient expression of Human papillomavirus type 16 L2 epitope fused to N- and C-terminus of coat protein of Potato virus X in plants. PMID: 22357210

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model. PMID: 9465097

Optimizing a Human Papillomavirus Type 16 L1-Based Chimaeric Gene for Expression in Plants. PMID: 30062095

 

 

详情请咨询 abinScience 亚洲区官方子公司 —— 武汉艾必赛生物技术有限公司


武汉艾必赛生物技术有限公司成立于 2023 年,是 abinScience 在亚洲地区设立的官方全资子公司,全面负责 abinScience 品牌在亚太市场的科研试剂推广、销售及技术支持工作。

依托严格的产品研发体系和国际化的质量管理标准,武汉艾必赛与 AtaGenix、ProteoGenix 等知名品牌保持长期战略合作,现已构建起涵盖抗体、重组蛋白、工具酶、试剂盒、实验耗材在内的多品类供应体系,面向区域内科研机构、高校实验室与生物医药企业,提供稳定、高效、可信赖的产品与服务。



核心业务覆盖:

? 抗体产品(单抗、多抗、重组抗体等)

? 蛋白与多肽试剂(标签蛋白、功能蛋白等)

? 分子与细胞实验相关耗材

? 定制化研发服务(蛋白表达、抗体定制、亲和力成熟等)

? 科研供应链整合与项目配套支持

武汉艾必赛始终秉持“Empowering Bioscience Discovery”的理念,为亚太地区的生命科学研究持续注入高质量动能。

 

新闻图片2


联系方式
微信扫一扫

返回顶部